Lantheus Corp - Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan LNTH

Lantheus Holdings, Inc. (LNTH) dominates the field of cardiac radiology due to exclusive drug rights. The EV/EBITDA valuation level shown on this GURU.Markets chart demonstrates the stability of cash cows with long life cycles. Meanwhile, success relies on insurance payouts and regulatory approvals, and the value of 17.28 captures this metric for market bottom analysis.
Rincian metrik lan analitis perusahaan Lantheus Holdings (LNTH)

Lantheus Holdings, Inc. (LNTH) is aggressively expanding its radiopharmaceutical portfolio and R&D platform for cancer diagnostics and therapy, which requires significant capital expenditures. An analysis of the Enterprise Value to EBITDA ratio allows for an assessment of the overall business value relative to its operating profit before taxes, depreciation, and amortization, helping investors determine if the asset is overvalued given the debt load and current market rates.